key: cord-0952737-o6nxaswh authors: Ortiz, Alberto; Vinck, Caroline title: Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021 date: 2022-03-31 journal: Clin Kidney J DOI: 10.1093/ckj/sfac023 sha: 7253d9a696737cdb9b5022fc980a4c4b17f7f8aa doc_id: 952737 cord_uid: o6nxaswh The year 2021 was the last full year of Alberto Ortiz’s editorship at Clinical Kidney Journal (CKJ). On May 2022, Maria José Soler will start her term as the Editor-in-Chief. Over these years, CKJ obtained its first journal impact factor and has consolidated its position among the top journals in the field, consistently ranking among the top 25% (first quartile) journals in Urology and Nephrology. The 2020 journal impact factor rose to 4.45, becoming the top open access journal in Nephrology and the ninth ranked Nephrology journal overall. We now review the recent history of the journal and the most highly cited topics which include the epidemiology of kidney disease, chronic kidney disease topics, such as the assessment and treatment of chronic kidney disease, onconephrology, cardionephrology, glomerular disease, transplantation and coronavirus disease 2019 (COVID-19). Ortiz has been the Editor-in-Chief (EiC), a term that will end in May 2022 when Maria José Soler will become the first female CKJ EiC [1, 2] . As the last full year as EiC ends, it is worth reflecting on the path so far and on the most impactful topics published in CKJ. The single event that has most influenced the trajectory of the journal during Alberto Ortiz's editorship was the journal's first impact factor (JIF) in 2019 [3] . Overnight, the number of submissions doubled and the quality increased, forcing the editorial board to make painful rejection decisions. Triaging became necessary and the acceptance rate for original manuscripts dropped to 10-15%. As of January 2021, the number of issues increased from 6 to 12 a year, to accelerate the speed of publication of new science. From the first JIF, CKJ has been part of the select group of journals ranked among the top 25% (first quartile, Q1) of Urology and Nephrology journals. Moreover, as the JIF progressively increased to over 3.0 and, most recently, to over 4.0, CKJ slowly climbed the ranks of Q1 journals. As of the summer of 2021, the 2020 JIF was 4.452 and Clarivate ranked CKJ as the top open access Nephrology journal and the ninth Nephrology journal overall (Table 1) . It was also the sixth ranked Nephrology journal among journals that publish mainly original research. FIGURE 1: Key milestones in the history of CKJ. Source for journal ranking: reference number [3] . It is worth reflecting on the items that drew the most citations over the years, the ones that most impacted other scientists and, potentially, clinical practice. The most cited manuscripts are presented in Table 2 and summarized per topic in Figure 2 [4-37]. Older items have had more time to build awareness and be cited and thus may be overrepresented. This issue is only partially addressed by the column depicting average citations per year, as there will be a lag time from publication to first notice by readers and to citation in the readers' manuscript, and this will be followed by a lag time from manuscript submission to publication. Thus, citations shown in Table 2 will more accurately reflect the impact of older items than of newer items, whose full impact will be realized in the next few years. To visualize newer items, Table 3 shows the top publications ranked according to average yearly citations and Table 4 the top five cited manuscripts from each year . While only one manuscript from 2019 or later is among the manuscripts with most overall citations ( Table 2) , 45% of manuscripts with the most annualized citations were from 2019 to 2021, illustrating the increased quality and visibility of CKJ contents (Table 3) . Overall, the most cited manuscripts had chronic kidney disease (CKD) as topic, either non-dialysis or dialysis CKD (Figure 2 ), followed by onconephrology, cardionephrology, glomerular disease and transplantation. In line with a recent bibliographical analysis, acute kidney injury (AKI) was remarkably underrepresented, except for the coronavirus disease 2019 (COVID-19) context in more recent years [61] . Tables 3 and 4 provide a greater granularity as well as the emergence of topics that have become more relevant in recent years (Table 5) . Thus, assessment of CKD by either improving glomerular filtration rate (GFR) assessment by using iohexol to measure GFR or novel methods for assessment of kidney injury, such as the urinary peptidomics biomarker CKD273, were highly cited topics [7, 11] . Regarding onconephrology, the nephrotoxicity of novel anticancer agents also attracted the attention of readers [12, 31, 34] . More recently, novel therapeutic approaches for CKD or its complications, such as sodium-glucose transport protein 2 (SGLT2) inhibitors or hypoxia-inducible factor (HIF) stabilizers, were also topics of interest [5, 39] , as well as several manuscripts dealing with the interaction between COVID-19 and kidney disease [38, 40, 44, 47, 56, 57, 59] . COVID-19-related highly cited manuscripts dealt with characterization of AKI in patients with severe COVID-19 and kidney replacement therapy in this context, COVID-19 in CKD and the key role that collective transport to and from hemodialysis units played in the spread of the disease among hemodialysis patients [38, 40, 44, 47] . Finally, topics at the top of the global agenda, such as the impact of air pollution on health and, specifically, on kidney disease have also been highly cited [41] . A special mention should be devoted to the concept of CKD hotspots, first formulated in CKJ as consisting of countries, regions, communities or ethnicities with higher-than-average incidence of CKJ publishes the summary of the ERA Registry Annual Report. This is one of the most cited items in the journal and was not included in the above analyses. It represents the longest running multinational registry that is searchable as a publication in PubMed. In recent years, Registry Reports have consistently ranked among the top 10 cited items per year, often on the top spot. Furthermore, their citation record has increased over the years [62] [63] [64] [65] [66] [67] [68] [69] . The most cited Registry Report was the 2015 2014 Onconephrology (nephrotoxicity of anticancer agents) and cardiovascular disease (anticoagulation) report published in 2018 [69] . That year, World Kidney Day was devoted to women and kidney disease, and the ERA Registry was a solid source of information on the epidemiology, treatment and outcomes of kidney replacement therapy in men and women [70, 71] . High-quality journals do not just happen. We should be grateful to the authors who considered CKJ to disseminate their expertise and research as well as the reviewers who devoted their time to constructively criticize and improve the quality of the manuscripts (Supplementary data, Tables S1-S8). Finally, a hardworking and expert editorial board liaised with reviewers and integrated their concerns to select the highest quality manuscripts that would be most informative and useful to our readership (Supplementary data, Table S9 ). A big thank you to all of you and good luck to our new Editor-in-Chief! Supplementary data are available at ckj online. CKD: Exercise and CKD 2016 CKD: Measured GFR 2017 CKD: Urinary peptidomics and pain 2018 CKD: SGLT2 inhibitors Onconephrology (checkpoint inhibitors) and CKD (HIF stabilizers) CKD (haemodialysis: medium cut-off dialyser The new Clinical Kidney Journal, 4 years later Ckj consolidation among Q1 Urology and Nephrology journals The potential for improving cardio-renal outcomes by sodium-glucose cotransporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study Effects of exercise in the whole spectrum of chronic kidney disease: a systematic review Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol? Chronic kidney disease in children Macrophage in chronic kidney disease Chronic kidney disease hotspots in developing countries in South Asia Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: why to measure glomerular filtration rate with iohexol? Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma A renal registry for Africa: first steps Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling The global nephrology workforce: emerging threats and potential solutions! The intestine and the kidneys: a bad marriage can be hazardous Frailty and chronic kidney disease: current evidence and continuing uncertainties update on pain management in patients with chronic kidney disease Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials Real-time ultrasoundguided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA Lymphatic disorders after renal transplantation: new insights for an old complication A comparative analysis of survival of patients on dialysis and after kidney transplantation The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury Anticoagulation in chronic kidney disease patients-the practical aspects Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network Gut microbiota and inflammation in chronic kidney disease patients Renal toxicities associated with pembrolizumab Focus on renal congestion in heart failure A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues Nephrotoxicity of recent anti-cancer agents Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019 Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis Coronavirus disease 2019 in chronic kidney disease Air pollution and kidney disease: review of current evidence Anemia and iron deficiency among chronic kidney disease stages 3-5ND patients in the chronic kidney disease outcomes and practice patterns study: often unmeasured, variably treated Effects of a medium cut-off (Theranova ®) dialyser on haemodialysis patients: a prospective, cross-over study Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis Clarifying the concept of chronic kidney disease for nonnephrologists Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study The keys to control a COVID-19 outbreak in a haemodialysis unit What do epidemiological studies tell us about chronic kidney disease of undetermined cause in Meso-America? A systematic review and meta-analysis CKD hotspots around the world: where, why and what the lessons are. A CKJ review series Renal replacement therapy in Latin American end-stage renal disease Incidence of acute kidney injury following total joint arthroplasty: a retrospective review by RIFLE criteria Cognitive function and advanced kidney disease: longitudinal trends and impact on decisionmaking Risk factors for bleeding complications after nephrologist-performed native renal biopsy External validation of prognostic models: what, why, how, when and where? Acute kidney injury pathology and pathophysiology: a retrospective review Pathology of COVID-19-associated acute kidney injury Kidney transplantation and COVID-19 renal and patient prognosis Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy Renin-angiotensin system blockade in the COVID-19 pandemic Tumor necrosis factor-alpha blockade ameliorates diabetic nephropathy in rats EDTAKI: a Nephrology and Public Policy Committee (NPPC) platform call for more European involvement in AKI The ERA-EDTA Registry Annual Report 2017: a summary The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary The European Renal Association-European Dialysis and Transplant Association Registry Annual Report 2014: a summary Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the Dutch registry of patient-reported outcome measures Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations Age-dependent reference intervals for estimated and measured glomerular filtration rate Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings Development and internal validation of a prediction model for hospital-acquired acute kidney injury Cellular origin and mi-croRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy Health claims databases used for kidney research around the world